Spectrum Pharmaceuticals Provides Update on ROLONTIS® (eflapegrastim) Pre-Approval Inspection

Go back to Spectrum Pharmaceuticals Provides Update on ROLONTIS® (eflapegrastim) Pre-Approval Inspection
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Delayed: 3.47 +0.03 (0.87%)
Previous Close $3.44    52 Week High $7.74 
Open $3.45    52 Week Low $3.21 
Day High $3.57    P/E N/A 
Day Low $3.43    EPS $-0.21 
Volume 2,087,384